Biopharmaceutical Research Company.
Education about access to innovative sickle cell disease therapies and proposed legislation to increase funding and care coordination for patients with sickle cell disease. H.R.6216/S.4866 - Sickle Cell Disease Comprehensive Care Act.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX